Literature DB >> 1941379

Thyroid function after treatment of brain tumors in children.

A L Ogilvy-Stuart1, S M Shalet, H R Gattamaneni.   

Abstract

In 134 children who had been treated for a brain tumor not involving the hypothalamic-pituitary axis, thyroid function was assessed up to 24 years after treatment with cranial or craniospinal irradiation. In addition, 78 children received up to 2 years of cytotoxic chemotherapy. Of 85 children who received craniospinal irradiation, 30 (35%) had abnormalities of thyroid function, and 10 (20%) of 49 who received cranial irradiation had such abnormalities. Frank hypothyroidism developed in three children and thyrotoxicosis in one. Thirty-six children had an elevated thyroid-stimulating hormone level in the presence of a normal thyroxine level; in 16 of them the thyroid-stimulating hormone level subsequently returned to normal. Twenty-eight children who were treated between 1960 and 1970 were excluded from the analysis. Of 34 children who received cranial irradiation, five had thyroid dysfunction and 24 of 72 who received craniospinal irradiation had such dysfunction (p = 0.013). Thyroid dysfunction was present in 4 of 35 children who received no chemotherapy and in 25 of 71 who received chemotherapy (p = 0.014). Direct irradiation plus chemotherapy was more damaging than irradiation alone. These data confirm the high incidence of thyroid dysfunction when the thyroid gland is included in the radiation field. However, in a high proportion, the thyroid abnormalities are minor and revert to normal with time; life-long replacement therapy with thyroxine may be unnecessary.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941379     DOI: 10.1016/s0022-3476(05)80288-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

Review 1.  Endocrine sequelae of cancer therapy in childhood.

Authors:  F B Diamond; B B Bercu
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols.

Authors:  A Corrias; S Einaudi; U Ricardi; A Sandri; L Besenzon; F Altare; L Artesani; L Genitori; M Andreo; C De Sanctis
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 3.  Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings.

Authors:  Lisa Diller; Eric J Chow; James G Gurney; Melissa M Hudson; Nina S Kadin-Lottick; Toana I Kawashima; Wendy M Leisenring; Lillian R Meacham; Ann C Mertens; Daniel A Mulrooney; Kevin C Oeffinger; Roger J Packer; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

4.  Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy.

Authors:  M Delvecchio; V Cecinati; L P Brescia; M F Faienza; D De Mattia; L Cavallo; N Santoro
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 5.  Cytotoxic endocrinopathy: a legacy of insults.

Authors:  S M Shalet
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

6.  The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation.

Authors:  Christine Lauro; Margaret E Macy; Philip Zeitler; Jennifer Backus; Pamela Mettler; Nicholas Foreman; Arthur K Liu
Journal:  J Pediatr Endocrinol Metab       Date:  2014-03       Impact factor: 1.634

Review 7.  Thyroid function in children treated for acute lymphoblastic leukemia.

Authors:  A Mohn; F Chiarelli; A Di Marzio; P Impicciatore; S Marsico; F Angrilli
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 8.  Late effects of antineoplastic therapy in childhood on growth and endocrine function.

Authors:  W H Wallace; C J Kelnar
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

9.  Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

Authors:  Eric J Chow; Debra L Friedman; Marilyn Stovall; Yutaka Yasui; John A Whitton; Leslie L Robison; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

Review 10.  Hypothyroidism after a cancer diagnosis: etiology, diagnosis, complications, and management.

Authors:  Yvette Carter; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.